2-(4-((2,4-Dioxothiazolidin-5-yl)methyl)phenoxy)acetic acid
CAS : 179087-93-5
Ref. 3D-EHA08793
| 1g | À demander |
Informations sur le produit
2-(4-((2,4-Dioxothiazolidin-5-yl)methyl)phenoxy)acetic acid (BMS-201038) is a novel drug that can be used to treat type 2 diabetes. It has been shown to reduce insulin resistance and increase insulin sensitivity in rodents when it is administered orally. BMS-201038 binds to the hydroxyl group of the active site of the enzyme inositol phosphatase, which regulates intracellular signaling pathways and glucose levels. This drug also has a hydroxyl group that may react with nucleophiles such as water or thiols, which may lead to its hydrolysis.
BMS-201038 also has two trifluoromethyl groups that could be oxidized by cytochrome P450 enzymes, leading to the formation of metabolites with different activities than those found in the parent compound.
Propriétés chimiques
Question d’ordre technique sur : 3D-EHA08793 2-(4-((2,4-Dioxothiazolidin-5-yl)methyl)phenoxy)acetic acid
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
